Andrew Norden, MD, says that he thinks the 2 companies' technologies together are "unsurpassed."
While disparate information can be linked back together, it is dependent on what the manufacturer is willing to pay.
If the patient is truly to be paramount, “I think a lot of effort still needs to be done,” John Giannouris said.
John Giannouris knows that the pharmaceutical industry is changing.
“There's a wonderful opportunity for computational biologists and people with computer science backgrounds to have an impact on experimental immunology."
Genomic research, according to Miraldi, is a big data problem, and one that can continually offer insight and inspiration.
"You want to understand very quickly where it is going and what value it brings to you,” he said.
Healthcare messaging used to be controlled in a hierarchical, top-down manner. The internet changed that.
Omri Shor sees 3 main forces in the healthcare industry colliding to create a “perfect storm” for better patient engagement technologies.
“If we give them ownership, it will help engagement [and] improve outcomes, because now they can get better care."
Become a contributor